Robert Hoffman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Hoffman
Robert Hoffman is recorded as CFO at FibroBiologics, Inc. (FBLG). FibroBiologics, Inc. reported in an 8-K filed October 29, 2024 that Robert Hoffman was appointed Interim Chief Financial Officer, effective October 30, 2024.
“The Company has appointed Mr. Robert Hoffman, 58, as Interim Chief Financial Officer, effective October 30, 2024 (the "Appointment Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-30–present
-
Start not stated–2024-07-08
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at FibroBiologics, Inc.
Other people whose current roles at this company are on record from its filings.
- Pete O’Heeron CEO, Board Member
- Jason D. Davis CFO
- Ruben A. Garcia General Counsel
- Kathleen Rubins Board Member
- Kathleen Rubins, Ph.D. Board Member
- Leigh Steinberg Board Member
- Pete O'Heeron Board Member
- Richard Cilento Board Member
- Robert E. Hoffman Board Member
- Stacy Coen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.